Clinical Trial

Reproductive Health Education, Birth Control and Sexual Quality of Life in Ectopic Pregnancy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 24, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Ectopic pregnancy (EP) is defined as the implantation of a fertilized ovum outside the uterine cavity, most commonly in the fallopian tubes. EP is a potentially life-threatening condition due to the risk of tubal rupture and intra-abdominal bleeding. Management of ectopic pregnancy may involve medical or surgical treatment, often requiring hospitalization. Following treatment and discharge, women may experience physical, emotional, and sexual health challenges. In addition, the need for effective contraception after ectopic pregnancy treatment is critical due to the risk of recurrent ectopic pregnancy and the potential teratogenic effects of treatment agents such as methotrexate. However, limited data are available regarding contraceptive intentions and sexual quality of life after ectopic pregnancy treatment in Türkiye. This study aims to evaluate contraceptive intention and sexual quality of life in women treated for ectopic pregnancy and to examine the relationship between length of hospital stay, contraceptive intention, and sexual quality of life. Data will be collected using the Participant Information Form, the Contraceptive Intention Scale (CIS), and the Sexual Life Quality Scale-Women (SLQS-W). In addition, a reproductive health educational brochure will be provided to participants as part of post-treatment counseling.
Trial Details
NCT Number NCT07431411
Lead Sponsor Buket Kömürcü
Collaborators: Izmir City Hospital, Ege University
Conditions Ectopic Pregnancy
Enrollment 102 participants
Start Date 2026-02-18
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-24